Targeting Imperfect Vaccines against Drug-Resistance Determinants: A Strategy for Countering the Rise of Drug Resistance

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Joice, Regina ^a   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PNEUMOCOCCUS VACCINE;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TARGETING; ESSENTIAL GENE; GENE PRODUCT; IMMUNITY; INFLUENZA VIRUS; NONHUMAN; POPULATION RESEARCH; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ANTIGENS, BACTERIAL; ANTIGENS, VIRAL; BACTERIAL VACCINES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, STATISTICAL; ORTHOMYXOVIRIDAE; PNEUMOCOCCAL INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VACCINES, SUBUNIT;

EID: 84880763256     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068940     Document Type: Article

References (62)

1. Lipsitch M, Samore MH, (2002) Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 8: 347-354.
2. Lipsitch M, Cohen T, Murray M, Levin BR, (2007) Antiviral resistance and the control of pandemic influenza. PLoS Med 4: e15.
3. Andersson DI, Levin BR, (1999) The biological cost of antibiotic resistance. Curr Opin Microbiol 2: 489-493.
4. Levin BR, Lipsitch M, Perrot V, Schrag S, Antia R, et al. (1997) The population genetics of antibiotic resistance. Clinical Infectious Diseases 24: S9-16.
5. Lipsitch M, (2001) The rise and fall of antimicrobial resistance. Trends Microbiol 9: 438-444.
6. Horn DL, Zabriskie JB, Austrian R, Cleary PP, Ferretti JJ, et al. (1998) Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis 26: 1341-1345.
7. Patel SN, McGeer A, Melano R, Tyrrell GJ, Green K, et al. (2011) Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Antimicrob Agents Chemother 55: 3703-3708.
8. Chambers HF, Deleo FR, (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7: 629-641.
9. Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, et al. (2007) The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 24: 1811-1820.
10. Moscona A, (2005) Oseltamivir resistance-disabling our influenza defenses. N Engl J Med 353: 2633-2636.
11. Colijn C, Cohen T, Fraser C, Hanage W, Goldstein E, et al. (2010) What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? J R Soc Interface 7: 905-919.
12. Centers for Disease Control and Prevention (2010) Gonococcal Isolate Surveillance Project (GISP) Profiles, 2010.
13. Dagan R, Klugman KP, (2008) Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 8: 785-795.
14. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, et al. (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354: 1455-1463.
15. Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, et al. (2009) Continued impact of pneumococcal conjugate vaccine on serotypes, antibiotic resistance, and risk factors for carriage in young children. Pediatrics 124: e1-11.
16. Zarantonelli ML, Antignac A, Lancellotti M, Guiyoule A, Alonso JM, et al. (2006) Immunogenicity of meningococcal PBP2 during natural infection and protective activity of anti-PBP2 antibodies against meningococcal bacteraemia in mice. J Antimicrob Chemother 57: 924-930.
17. Beutner KR, Chow T, Rubi E, Strussenberg J, Clement J, et al. (1979) Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. J Infect Dis 140: 844-850.
18. Pages JM, James CE, Winterhalter M, (2008) The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 6: 893-903.
19. Nikaido H, Pages JM, (2012) Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 36: 340-363.
20. Rossolini GM, Mantengoli E, Montagnani F, Pollini S, (2010) Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents. Curr Opin Microbiol 13: 582-588.
21. Charpentier E, Tuomanen E, (2000) Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect 2: 1855-1864.
22. Zhu YH, Gao YF, Chen F, Liu W, Zhai MX, et al. (2011) Identification of novel T cell epitopes from efflux pumps of Mycobacterium tuberculosis. Immunol Lett 140: 68-73.
23. Kaufmann SH, (2005) Recent findings in immunology give tuberculosis vaccines a new boost. Trends Immunol 26: 660-667.
24. Malley R, Anderson PW, (2012) Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc Natl Acad Sci U S A 109: 3623-3627.
25. Baquero F, Coque TM, de la Cruz F, (2011) Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob Agents Chemother 55: 3649-3660.
26. Lipsitch M, Bergstrom CT, Levin BR, (2000) The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci U S A 97: 1938-1943.
27. Temime L, Guillemot D, Boelle PY, (2004) Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob Agents Chemother 48: 2206-2213.
28. Tekle YI, Nielsen KM, Liu J, Pettigrew MM, Meyers LA, et al. (2012) Controlling Antimicrobial Resistance through Targeted, Vaccine-Induced Replacement of Strains. PLoS One 7: e50688.
29. Link-Gelles R, Thomas A, Lynfield R, Petit S, Schaffner W, et al. Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the postvaccine era in the United States. Journal of Infectious Diseases In Press.
30. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, et al. (2000) Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States. N Engl J Med 343: 1917-1924.
31. Hicks LA, Chien YW, Taylor TH Jr, Haber M, Klugman KP, (2011) Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis 53: 631-639.
32. Musher DM, (2006) Pneumococcal vaccine-direct and indirect ("herd") effects. N Engl J Med 354: 1522-1524.
33. Grijalva CG, Nuorti JP, Griffin MR, (2009) Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 302: 758-766.
34. Nielsen KL, Pedersen TM, Udekwu KI, Petersen A, Skov RL, et al. (2012) Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. J Antimicrob Chemother 67: 1325-1332.
35. Osterholm MT, Kelley NS, Sommer A, Belongia EA, (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12: 36-44.
36. Trzcinski K, Thompson CM, Gilbey AM, Dowson CG, Lipsitch M, (2006) Incremental increase in fitness cost with increased beta-lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model. J Infect Dis 193: 1296-1303.
37. Andersson DI, Hughes D, (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nature reviews Microbiology 8: 260-271.
38. Lee GM, Huang SS, Rifas-Shiman SL, Hinrichsen VL, Pelton SI, et al. (2009) Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis 9: 110.
39. Lo WT, Wang CC, Lin WJ, Wang SR, Teng CS, et al. (2010) Changes in the nasal colonization with methicillin-resistant Staphylococcus aureus in children: 2004-2009. PLoS One 5: e15791.
40. Wang JT, Liao CH, Fang CT, Chie WC, Lai MS, et al. (2009) Prevalence of and risk factors for colonization by methicillin-resistant Staphylococcus aureus among adults in community settings in Taiwan. J Clin Microbiol 47: 2957-2963.
41. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, et al. (2008) Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 197: 1226-1234.
42. Creech CB 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM, (2005) Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 24: 617-621.
43. Sabol KE, Echevarria KL, Lewis JS 2nd, (2006) Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs. Ann Pharmacother 40: 1125-1133.
44. Otto M, (2012) MRSA virulence and spread. Cell Microbiol 14: 1513-1521.
45. Queck SY, Khan BA, Wang R, Bach TH, Kretschmer D, et al. (2009) Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog 5: e1000533.
46. Chao DL, Bloom JD, Kochin BF, Antia R, Longini IM Jr, (2012) The global spread of drug-resistant influenza. J R Soc Interface 9: 648-656.
47. Li Y, Gierahn T, Thompson CM, Trzcinski K, Ford CB, et al. (2012) Distinct Effects on Diversifying Selection by Two Mechanisms of Immunity against Streptococcus pneumoniae. PLoS Pathog 8: e1002989.
48. Dagan R, Givon-Lavi N, Zamir O, Sikuler-Cohen M, Guy L, et al. (2002) Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 185: 927-936.
49. CDC (2009) National Hospital Discharge Survey: 2009 table, Number and rate of hospital discharges.
50. Lipsitch M, (1997) Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A 94: 6571-6576.
51. Huang SS, Datta R, Rifas-Shiman S, Kleinman K, Placzek H, et al. (2011) Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study. Crit Care 15: R210.
52. Aly R, Maibach HI, Shinefield HR, Mandel A, Strauss WG, (1974) Bacterial interference among strains of Staphylococcus aureus in man. J Infect Dis 129: 720-724.
53. Weinberger D, Malley R, Lipsitch M, (2011) Serotype replacement in disease following pneumococcal vaccination. Lancet 378: 1962-1973.
54. Goldstein E, Cobey S, Takahashi S, Miller JC, Lipsitch M, (2011) Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method. PLoS Med 8: e1001051.
55. May RM, Anderson RM, (1990) Parasite-host coevolution. Parasitology 100: S89-S101.
56. Mattner F, Biertz F, Ziesing S, Gastmeier P, Chaberny IF, (2010) Long-term persistence of MRSA in re-admitted patients. Infection 38: 363-371.
57. Nilsson P, Ripa T, (2006) Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares. J Clin Microbiol 44: 3334-3339.
58. Bogaert D, De Groot R, Hermans PW, (2004) Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4: 144-154.
59. Finkelstein JA, Davis RL, Dowell SF, Metlay JP, Soumerai SB, et al. (2001) Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 108: 1-7.
60. Ekdahl K, Ahlinder I, Hansson HB, Melander E, Molstad S, et al. (1997) Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project. Clin Infect Dis 25: 1113-1117.
61. Hogberg L, Geli P, Ringberg H, Melander E, Lipsitch M, et al. (2007) Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J Clin Microbiol 45: 948-952.
62. CDC (2012) Vaccination coverage among children in kindergarten-United States, 2011-12 school year. MMWR Morb Mortal Wkly Rep 61: 647-652.